Avidity Biosciences Inc
RNA
Market Cap$3.36B
Close$
$-1.44
105.2% downside
Current Fair Value
105.2% downsideOvervalued by 105.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.36 Billion |
|---|---|
| Enterprise Value | $3.17 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.89 |
| Beta | 0.99 |
| Outstanding Shares | 128,497,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -11.11 |
|---|---|
| PEG | -20.75 |
| Price to Sales | - |
| Price to Book Ratio | 2.53 |
| Enterprise Value to Revenue | 313.02 |
| Enterprise Value to EBIT | -9.75 |
| Enterprise Value to Net Income | -12 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data